Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Therapeutic use of cannabis derivatives].
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Early diagnosis of Balo's concentric sclerosis by diffusion tensor tractography: a case report and literature review.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Laser speckle imaging to improve clinical outcomes for patients with trigeminal neuralgia undergoing radiofrequency thermocoagulation.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Preferences of Patients With Multiple Sclerosis for Attributes of Disease Modifying Drugs In Decision-Making: A Nominal Group Technique And Best-Worst Scaling.
Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
European multiple sclerosis risk variants in the south Asian population.
Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
Lung volume recruitment in multiple sclerosis.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Analysis of the treatment of neuromyelitis optica.
Diagnosis and quantification of cognitive fatigue in multiple sclerosis.
Pages
« first
‹ previous
…
538
539
540
541
542
543
544
545
546
…
next ›
last »